Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1991 Oct;35(10):2070–2077. doi: 10.1128/aac.35.10.2070

Shell-vial assay: evaluation of a new technique for determining antibiotic susceptibility, tested in 13 isolates of Coxiella burnetii.

D Raoult 1, H Torres 1, M Drancourt 1
PMCID: PMC245328  PMID: 1759829

Abstract

Coxiella burnetii is a strictly intracellular bacterium. Bacteriostatic effects have been described previously on a few isolates in embryonated eggs (A. J. Spicer, M. G. Peacock, and J. C. Williams, p. 375-383, in W. Burgdorfer and R. L. Anacker, ed., Rickettsiae and rickettsial diseases, 1981). We used the shell-vial technique (D. Raoult, G. Vestris, and M. Enea, J. Clin. Microbiol. 28:2482-2484, 1990) to determine the susceptibility of C. burnetii to amoxicillin, amikacin, erythromycin, co-trimoxazole, pefloxacin, ofloxacin, ciprofloxacin, chloramphenicol, tetracycline, doxycycline, minocycline, and rifampin antibiotics at a single dilution. Human embryonic lung fibroblast monolayers in shell vials were seeded with 13 different C. burnetii isolates, including 3 reference strains (Nine Mile, Q212, and Priscilla) and 10 new isolates, in order to obtain 30% infected cells 6 days later. After inoculation, antibiotics were added, shell vials were incubated for 7 days, and immunofluorescence was revealed and compared with that of the positive controls. Strain Nine Mile was more susceptible than strains Q212 and Priscilla were. The heterogeneity of susceptibility to fluoroquinolones, chloramphenicol, and erythromycin was noted among the strains; all were resistant to amoxicillin and amikacin, and all were susceptible to rifampin, co-trimoxazole, tetracycline, and tetracycline analogs.

Full text

PDF
2070

Images in this article

2072Image
on p.2072
2073Image
on p.2073
2074Image
on p.2074
2075Image
on p.2075

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baca O. G., Paretsky D. Q fever and Coxiella burnetii: a model for host-parasite interactions. Microbiol Rev. 1983 Jun;47(2):127–149. doi: 10.1128/mr.47.2.127-149.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Ellis M. E., Smith C. C., Moffat M. A. Chronic or fatal Q-fever infection: a review of 16 patients seen in North-East Scotland (1967-80). Q J Med. 1983 Winter;52(205):54–66. [PubMed] [Google Scholar]
  3. Freeman R., Hodson M. E. Q fever endocarditis treated with trimethoprim and sulphamethoxazole. Br Med J. 1972 Feb 12;1(5797):419–420. doi: 10.1136/bmj.1.5797.419. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Hackstadt T. The role of lipopolysaccharides in the virulence of Coxiella burnetii. Ann N Y Acad Sci. 1990;590:27–32. doi: 10.1111/j.1749-6632.1990.tb42203.x. [DOI] [PubMed] [Google Scholar]
  5. Haldane E. V., Marrie T. J., Faulkner R. S., Lee S. H., Cooper J. H., MacPherson D. D., Montague T. J. Endocarditis due to Q fever in Nova Scotia: experience with five patients in 1981-1982. J Infect Dis. 1983 Dec;148(6):978–985. doi: 10.1093/infdis/148.6.978. [DOI] [PubMed] [Google Scholar]
  6. Kimbrough R. C., 3rd, Ormsbee R. A., Peacock M., Rogers W. R., Bennetts R. W., Raaf J., Krause A., Gardner C. Q fever endocarditis in the United States. Ann Intern Med. 1979 Sep;91(3):400–402. doi: 10.7326/0003-4819-91-3-400. [DOI] [PubMed] [Google Scholar]
  7. Levy P. Y., Drancourt M., Etienne J., Auvergnat J. C., Beytout J., Sainty J. M., Goldstein F., Raoult D. Comparison of different antibiotic regimens for therapy of 32 cases of Q fever endocarditis. Antimicrob Agents Chemother. 1991 Mar;35(3):533–537. doi: 10.1128/aac.35.3.533. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. ORMSBEE R. A., PARKER H., PICKENS E. G. The comparative effectiveness of aureomycin, terramycin, chloramphenicol erythromycin, and thiocymetin in suppressing experimental rickettsial infections in chick embryos. J Infect Dis. 1955 Mar-Apr;96(2):162–167. doi: 10.1093/infdis/96.2.162. [DOI] [PubMed] [Google Scholar]
  9. POWELL O. W., KENNEDY K. P., McIVER M., SILVERSTONE H. Tetracycline in the treatment of "Q" fever. Australas Ann Med. 1962 Aug;11:184–188. doi: 10.1111/imj.1962.11.3.184. [DOI] [PubMed] [Google Scholar]
  10. Peacock M. G., Philip R. N., Williams J. C., Faulkner R. S. Serological evaluation of O fever in humans: enhanced phase I titers of immunoglobulins G and A are diagnostic for Q fever endocarditis. Infect Immun. 1983 Sep;41(3):1089–1098. doi: 10.1128/iai.41.3.1089-1098.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Raffi F. Q-fever endocarditis. Lancet. 1989 Dec 2;2(8675):1336–1337. doi: 10.1016/s0140-6736(89)91943-0. [DOI] [PubMed] [Google Scholar]
  12. Raoult D., Drancourt M., Vestris G. Bactericidal effect of doxycycline associated with lysosomotropic agents on Coxiella burnetii in P388D1 cells. Antimicrob Agents Chemother. 1990 Aug;34(8):1512–1514. doi: 10.1128/aac.34.8.1512. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Raoult D., Etienne J., Massip P., Iaocono S., Prince M. A., Beaurain P., Benichou S., Auvergnat J. C., Mathieu P., Bachet P. Q fever endocarditis in the south of France. J Infect Dis. 1987 Mar;155(3):570–573. doi: 10.1093/infdis/155.3.570. [DOI] [PubMed] [Google Scholar]
  14. Raoult D. Host factors in the severity of Q fever. Ann N Y Acad Sci. 1990;590:33–38. doi: 10.1111/j.1749-6632.1990.tb42204.x. [DOI] [PubMed] [Google Scholar]
  15. Raoult D., Levy P. Y., Harlé J. R., Etienne J., Massip P., Goldstein F., Micoud M., Beytout J., Gallais H., Remy G. Chronic Q fever: diagnosis and follow-up. Ann N Y Acad Sci. 1990;590:51–60. doi: 10.1111/j.1749-6632.1990.tb42206.x. [DOI] [PubMed] [Google Scholar]
  16. Raoult D., Piquet P., Gallais H., de Micco C., Drancourt M., Casanova P. Coxiella burnetii infection of a vascular prosthesis. N Engl J Med. 1986 Nov 20;315(21):1358–1359. [PubMed] [Google Scholar]
  17. Raoult D., Vestris G., Enea M. Isolation of 16 strains of Coxiella burnetii from patients by using a sensitive centrifugation cell culture system and establishment of the strains in HEL cells. J Clin Microbiol. 1990 Nov;28(11):2482–2484. doi: 10.1128/jcm.28.11.2482-2484.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Raoult D., Yeaman M. R., Baca O. G. Susceptibility of Coxiella burnetii to pefloxacin and ofloxacin in ovo and in persistently infected L929 cells. Antimicrob Agents Chemother. 1989 May;33(5):621–623. doi: 10.1128/aac.33.5.621. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Samuel J. E., Frazier M. E., Kahn M. L., Thomashow L. S., Mallavia L. P. Isolation and characterization of a plasmid from phase I Coxiella burnetii. Infect Immun. 1983 Aug;41(2):488–493. doi: 10.1128/iai.41.2.488-493.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Samuel J. E., Frazier M. E., Mallavia L. P. Correlation of plasmid type and disease caused by Coxiella burnetii. Infect Immun. 1985 Sep;49(3):775–779. doi: 10.1128/iai.49.3.775-779.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Tobin M. J., Cahill N., Gearty G., Maurer B., Blake S., Daly K., Hone R. Q fever endocarditis. Am J Med. 1982 Mar;72(3):396–400. doi: 10.1016/0002-9343(82)90495-8. [DOI] [PubMed] [Google Scholar]
  22. Tunstall Pedoe H. D. Apparent recurrence of Q fever endocarditis following homograft replacement of aortic valve. Br Heart J. 1970 Jul;32(4):568–570. doi: 10.1136/hrt.32.4.568. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Turck W. P., Howitt G., Turnberg L. A., Fox H., Longson M., Matthews M. B., Das Gupta R. Chronic Q fever. Q J Med. 1976 Apr;45(178):193–217. [PubMed] [Google Scholar]
  24. Turck W. P., Matthews M. B. Rickettsial endocarditis. Br Med J. 1969 Jan 18;1(5637):185–186. doi: 10.1136/bmj.1.5637.185-d. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Varma M. P., Adgey A. A., Connolly J. H. Chronic Q fever endocarditis. Br Heart J. 1980 Jun;43(6):695–699. doi: 10.1136/hrt.43.6.695. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Wilson H. G., Neilson G. H., Galea E. G., Stafford G., O'Brien M. F. Q fever endocarditis in Queensland. Circulation. 1976 Apr;53(4):680–684. doi: 10.1161/01.cir.53.4.680. [DOI] [PubMed] [Google Scholar]
  27. Yeaman M. R., Baca O. G. Unexpected antibiotic susceptibility of a chronic isolate of Coxiella burnetii. Ann N Y Acad Sci. 1990;590:297–305. doi: 10.1111/j.1749-6632.1990.tb42236.x. [DOI] [PubMed] [Google Scholar]
  28. Yeaman M. R., Mitscher L. A., Baca O. G. In vitro susceptibility of Coxiella burnetii to antibiotics, including several quinolones. Antimicrob Agents Chemother. 1987 Jul;31(7):1079–1084. doi: 10.1128/aac.31.7.1079. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Yeaman M. R., Roman M. J., Baca O. G. Antibiotic susceptibilities of two Coxiella burnetii isolates implicated in distinct clinical syndromes. Antimicrob Agents Chemother. 1989 Jul;33(7):1052–1057. doi: 10.1128/aac.33.7.1052. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Yebra M., Ortigosa J., Albarrán F., Crespo M. G. Ciprofloxacin in a case of Q fever endocarditis. N Engl J Med. 1990 Aug 30;323(9):614–614. doi: 10.1056/NEJM199008303230917. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES